Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
By leveraging detailed genetic insights, we create a more precise approach to your weight loss and overall health
While the few clinical trials completed so far have shown mixed results, the overall signals are encouraging
Survodutide (BI 456906) is another promising dual GLP-1R/GCGR agonist under development for the treatment of T2D, obesity, and NASH
As a worked climb on the 10 mg vial (5 mg/mL): 2.5 mg = 0.25 mL = 25 units
Affordability varies significantly depending on insurance coverage, pharmacy choice, and formulation type
Pricing is likewise subject to change at any time due to market conditions, vendor adjustments, or regulatory factors
US$ 26.52
US$ 24.85
US$ 20.60
US$ 25.61
US$ 23.29
US$ 21.12
US$ 26.37
US$ 27.74
US$ 29.08
